Pathologic complete response does not predict overall or disease-free survival in patients with rectal cancer, according to a ...

Rectal cancer chemoradiotherapy is tied to an increased risk for second nonpelvic cancers but not second pelvic cancers.

New research reveals that updated colorectal cancer screening among younger Americans has led to significant increases in local-stage tumor detection and diagnoses.

A research team at National Taiwan University has developed a new stem cell-based vaccine that could help prevent and treat ...

Colorectal cancer is the third most common cancer worldwide, resulting in 50,000 deaths annually in the U.S. alone.

TRIPLE-NEGATIVE breast cancer (TNBC) remains one of the most aggressive subtypes of breast cancer, with limited targeted ...

Automatically mailing a stool test kit to people's homes might be the best way to boost colon cancer screening among younger ...

Bristol-Myers Squibb’s KRAS inhibitor Krazati has been approved for a second indication, colorectal cancer (CRC), which could inject some much-needed sales growth into the product. The FDA has ...

After turning down Takeda's Fruzaqla for metastatic colorectal cancer (mCRC) in draft guidance last year, NICE has changed its mind and recommended the drug for use by the NHS in England and Wales.

Objective Metastasis is the major cause of cancer death. However, what types of heterogenous cancer cells in primary tumour and how they metastasise to the target organs remain largely undiscovered.

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.